SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-000217
Filing Date
2020-01-06
Accepted
2020-01-06 16:22:56
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4175
  Complete submission text file 0001562180-20-000217.txt   5746
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD CINCINNATI OH 45242
Business Address
PAKOLA STEVE (Reporting) CIK: 0001700659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 20509996